Interphase Cytogenetics Reveals a High Incidence of Aneuploidy and Intra-tumour Heterogeneity in Breast Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1995 Jul 1

PMID 7599066

Citations 10

Authors

M Fiegl

C Tueni

T Schenk

R Jakesz

M Gnant

A Reiner

M Rudas

H Pirc-Danoewinata

C Marosi

H HUBER

Affiliations

Soon will be listed here.

Abstract

The occurrence of aberrations involving chromosomes 11 and 17 in malignant tissues of breast cancer patients has not yet been studied systematically. Using fluorescence in situ hybridisation (FISH) with centromere-specific probes, we determined chromosome 11 and 17 status in interphase nuclei from primary and/or metastatic breast cancer cells. In all cancerous specimens obtained from 30 patients, FISH identified cells with clonal chromosomal abnormalities, with aneuploidy rates ranging from 6% to 92% (median 59%). There was a gain of centromeric signals for chromosome 11, most likely corresponding to hyperploidy; aberrations of chromosome 17 in specimens from 26 patients (87%) were hyperploid as well; however, four cases (13%) showed loss of chromosome 17 centromeres. All specimens contained heterogeneous aneuploid cell populations with excessive gain of signals in some cases. The pattern of aneuploidy did not appear to correlate with tumour grade/stage and was comparable in primary tumours and corresponding metastatic axillary lymph nodes, indicative of genetic instability early in tumour development. Screening with a panel of FISH probes may lead to enhanced sensitivity and specificity in detecting malignant cells, as demonstrated in this study with effusions which could not be conclusively interpreted as being malignant by cytological criteria.

Citing Articles

The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness.

Andrade de Oliveira K, Sengupta S, Yadav A, Clarke R Front Endocrinol (Lausanne). 2023; 14:1083048.

PMID: 36909339 PMC: 9997040. DOI: 10.3389/fendo.2023.1083048.

Tumor Heterogeneity in Breast Cancer.

Turashvili G, Brogi E Front Med (Lausanne). 2017; 4:227.

PMID: 29276709 PMC: 5727049. DOI: 10.3389/fmed.2017.00227.

Cancer genomics: one cell at a time.

Navin N Genome Biol. 2014; 15(8):452.

PMID: 25222669 PMC: 4281948. DOI: 10.1186/s13059-014-0452-9.

Future medical applications of single-cell sequencing in cancer.

Navin N, Hicks J Genome Med. 2011; 3(5):31.

PMID: 21631906 PMC: 3219072. DOI: 10.1186/gm247.

Inferring tumor progression from genomic heterogeneity.

Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J Genome Res. 2009; 20(1):68-80.

PMID: 19903760 PMC: 2798832. DOI: 10.1101/gr.099622.109.

References

Bentz M, Schroder M, Herz M, Stilgenbauer S, Lichter P, Dohner H . Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia. 1993; 7(5):752-7. View

Devilee P, Cornelisse C . Somatic genetic changes in human breast cancer. Biochim Biophys Acta. 1994; 1198(2-3):113-30. DOI: 10.1016/0304-419x(94)90009-4. View

Shay J, Wright W, Werbin H . Toward a molecular understanding of human breast cancer: a hypothesis. Breast Cancer Res Treat. 1993; 25(1):83-94. DOI: 10.1007/BF00662404. View

Winqvist R, Mannermaa A, Alavaikko M, Blanco G, TASKINEN P, Kiviniemi H . Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res. 1993; 53(19):4486-8. View

Gnant M, Blijham G, Reiner A, Schemper M, Reynders M, Schutte B . Aneuploidy fraction but not DNA index is important for the prognosis of patients with stage I and II breast cancer--10-year results. Ann Oncol. 1993; 4(8):643-50. DOI: 10.1093/oxfordjournals.annonc.a058618. View

Kibbelaar R, Kok F, Dreef E, Kleiverda J, Cornelisse C, Raap A . Statistical methods in interphase cytogenetics: an experimental approach. Cytometry. 1993; 14(7):716-24. DOI: 10.1002/cyto.990140704. View

Loy T, Bickel J, CHAPMAN R . Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases. Diagn Cytopathol. 1993; 9(5):516-21. DOI: 10.1002/dc.2840090509. View

Bandyk M, Zhao L, Troncoso P, Pisters L, Palmer J, Von Eschenbach A . Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer. 1994; 9(1):19-27. DOI: 10.1002/gcc.2870090105. View

Brugger W, Bross K, GLATT M, Weber F, Mertelsmann R, Kanz L . Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood. 1994; 83(3):636-40. View

10.

Micale M, Visscher D, Gulino S, WOLMAN S . Chromosomal aneuploidy in proliferative breast disease. Hum Pathol. 1994; 25(1):29-35. DOI: 10.1016/0046-8177(94)90167-8. View

11.

Kirchweger R, Zeillinger R, Schneeberger C, SPEISER P, Louason G, Theillet C . Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer. 1994; 56(2):193-9. DOI: 10.1002/ijc.2910560208. View

12.

Kallioniemi A, Kallioniemi O, Piper J, Tanner M, Stokke T, Chen L . Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A. 1994; 91(6):2156-60. PMC: 43329. DOI: 10.1073/pnas.91.6.2156. View

13.

Baars J, De Ruijter J, Smedts F, van Niekerk C, Poels L, Seldenrijk C . The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas. Am J Clin Pathol. 1994; 101(3):257-61. DOI: 10.1093/ajcp/101.3.257. View

14.

Menard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E . Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer. 1994; 69(6):1126-9. PMC: 1969436. DOI: 10.1038/bjc.1994.221. View

15.

Banks E, Jennings C, Jacobs S, Davey D . Comparative assessment of DNA analysis in effusions by image analysis and flow cytometry. Diagn Cytopathol. 1994; 10(1):62-6; discussion 66-7. DOI: 10.1002/dc.2840100116. View

16.

Cajulis R, Haines 3rd G, McVary K . Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes. Anal Quant Cytol Histol. 1994; 16(1):1-10. View

17.

Cornelisse C . DNA image cytometry on machine-selected breast cancer cells and a comparison between flow cytometry and scanning cytophotometry. Cytometry. 1985; 6(5):471-7. DOI: 10.1002/cyto.990060512. View

18.

Pinkel D, Straume T, Gray J . Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci U S A. 1986; 83(9):2934-8. PMC: 323421. DOI: 10.1073/pnas.83.9.2934. View

19.

Cremer T, Landegent J, Bruckner A, Scholl H, Schardin M, Hager H . Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum Genet. 1986; 74(4):346-52. DOI: 10.1007/BF00280484. View

20.

Hopman A, Ramaekers F, Raap A, Beck J, Devilee P, VAN DER PLOEG M . In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 1988; 89(4):307-16. DOI: 10.1007/BF00500631. View